8-K Announcements
6Material company update
May 18, 2026·SEC
Material company update
May 13, 2026·SEC
Material company update
May 8, 2026·SEC
Assertio Holdings, Inc.(ASRT)Earnings, Financials & Key Ratios
ASRT•NASDAQ
Price updated Jun 19, 2026
AboutAssertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate acute pain; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.Show more
- Revenue$119M-5.0%
- EBITDA$13M+844.7%
- Net Income-$30M-40.7%
- EPS (Diluted)-4.74-37.4%
- Gross Margin44.92%-34.5%
- EBITDA Margin10.77%+894.5%
- Operating Margin-14.51%+25.9%
- Net Margin-25.59%-48.2%
- ROE-28.25%-69.6%
ASRT Key Insights
Assertio Holdings, Inc. (ASRT) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 99 (top 1%)
- ✓Trading near 52-week high
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ASRT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ASRT Price & Volume
Assertio Holdings, Inc. (ASRT) stock price & volume — 10-year historical chart
Loading chart...
ASRT Growth Metrics
Assertio Holdings, Inc. (ASRT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-10.06%
5 Years1.9%
3 Years-8.75%
TTM-14.16%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-16.59%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-19.06%
Return on Capital
10 Years-16.2%
5 Years-19.83%
3 Years-39.94%
Last Year-11.13%
ASRT Recent Earnings
Assertio Holdings, Inc. (ASRT) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 8, 2026Metric
Actual
Est
EPS
$2.93-53.4%
$1.91
Rev
$10M+10.8%
$9M
Q2 2026
Mar 16, 2026Metric
Actual
Est
EPS
$1.86+39.0%
$3.05
Rev
$14M+118.5%
$6M
Q4 2025
Nov 10, 2025Metric
Actual
Est
EPS
$1.65+237.5%
$1.20
Rev
$49M+697.9%
$6M
Q3 2025
Aug 11, 2025Metric
Actual
Est
EPS
$0.17-70.0%
$0.10
Rev
$29M-0.3%
$29M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 8, 2026 | $2.93vs $1.91-53.4% | $10Mvs $9M+10.8% |
| Q2 2026 | Mar 16, 2026 | $1.86vs $3.05+39.0% | $14Mvs $6M+118.5% |
| Q4 2025 | Nov 10, 2025 | $1.65vs $1.20+237.5% | $49Mvs $6M+697.9% |
| Q3 2025 | Aug 11, 2025 | $0.17vs $0.10-70.0% | $29Mvs $29M-0.3% |
Based on last 12 quarters of dataView full earnings history →
ASRT Peer Comparison
Assertio Holdings, Inc. (ASRT) competitors in Specialty pharma brand consolidators — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 PAHC | 1.29B | 31.85 | 26.76 | 27.37% | 6.29% | 30.81% | 2.67 | |
 AMRX | 5.1B | 16.21 | 73.68 | 8.05% | 2.39% | 7.47% | 0.13 | |
 SUPN | 2.56B | 44.38 | -65.26 | 8.63% | -3.74% | -2.73% | 0.04 | |
 PRGO | 1.42B | 10.25 | -1.00 | -2.75% | -43.5% | -50.65% | 1.35 | |
 COLL | 1.09B | 33.54 | 19.39 | 23.62% | 9.41% | 26.74% | 3.12 | |
 HRMY | 1.93B | 33.28 | 12.28 | 21.51% | 16.2% | 17.19% | 0.28 | |
 AVDL | 2.1B | 21.64 | -42.43 | 5.05% | -0.11% | -0.33% | 0.02 | |
 BHC | 1.78B | 4.77 | 11.09 | 8.53% | -11.27% | 5.88% | 56.36 |
Compare ASRT vs Peers
Assertio Holdings, Inc. (ASRT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ASRT Income Statement
Assertio Holdings, Inc. (ASRT) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 380.72M | 311.77M | 229.53M | 108.08M | 111.01M | 156.23M | 152.07M | 124.96M | 118.71M | 102.16M |
Revenue Growth % | -16.49% | -18.11% | -26.38% | -52.91% | 2.72% | 40.73% | -2.67% | -17.83% | -5% | -14.16% |
Cost of Goods Sold | 72.6M | 18.48M | 9.51M | 15.77M | 15.83M | 18.75M | 27.02M | 39.23M | 65.39M | 56.88M |
COGS % of Revenue | 19.07% | 5.93% | 4.14% | 14.59% | 14.26% | 12% | 17.77% | 31.39% | 55.08% | - |
Gross Profit | 308.13M▲ 0% | 293.29M▼ 4.8% | 220.02M▼ 25.0% | 92.3M▼ 58.0% | 95.18M▲ 3.1% | 137.49M▲ 44.4% | 125.05M▼ 9.0% | 85.73M▼ 31.4% | 53.33M▼ 37.8% | 45.27M▲ 0% |
Gross Margin % | 80.93% | 94.07% | 95.86% | 85.41% | 85.74% | 88% | 82.23% | 68.61% | 44.92% | 44.32% |
Gross Profit Growth % | -16.38% | -4.81% | -24.98% | -58.05% | 3.12% | 44.45% | -9.05% | -31.44% | -37.8% | - |
Operating Expenses | 337.06M | 229.03M | 414.45M | 174.46M | 85.76M | 98.08M | 368.58M | 110.21M | 70.55M | 68.02M |
OpEx % of Revenue | 88.53% | 73.46% | 180.57% | 161.42% | 77.25% | 62.78% | 242.38% | 88.2% | 59.43% | - |
Selling, General & Admin | 195.69M | 119.22M | 110.44M | 104.22M | 56.55M | 48.1M | 69.74M | 76.95M | 68.86M | 66.32M |
SG&A % of Revenue | 51.4% | 38.24% | 48.12% | 96.43% | 50.94% | 30.79% | 45.86% | 61.58% | 58% | - |
Research & Development | 38.62M | 8.04M | 10.11M | 4.21M | 0 | 0 | 2.84M | 3.82M | 1.69M | 1.71M |
R&D % of Revenue | 10.14% | 2.58% | 4.4% | 3.9% | - | - | 1.87% | 3.06% | 1.42% | - |
Other Operating Expenses | 102.75M | 101.77M | 293.9M | 66.03M | 29.2M | 49.98M | 296M | 29.44M | 0 | 0 |
Operating Income | -42.18M▲ 0% | 43.66M▲ 203.5% | -194.43M▼ 545.3% | -82.16M▲ 57.7% | 9.42M▲ 111.5% | 39.41M▲ 318.1% | -243.54M▼ 718.0% | -24.48M▲ 89.9% | -17.22M▲ 29.6% | -22.75M▲ 0% |
Operating Margin % | -11.08% | 14% | -84.71% | -76.02% | 8.49% | 25.22% | -160.15% | -19.59% | -14.51% | -22.27% |
Operating Income Growth % | -272.1% | 203.51% | -545.33% | 57.75% | 111.47% | 318.13% | -718.03% | 89.95% | 29.63% | - |
EBITDA | 63.32M | 150.09M | -91.48M | -55.72M | 38.54M | 72.8M | -215.31M | 1.35M | 12.78M | 3.83M |
EBITDA Margin % | 16.63% | 48.14% | -39.86% | -51.56% | 34.71% | 46.6% | -141.59% | 1.08% | 10.77% | 3.74% |
EBITDA Growth % | -52.7% | 137.02% | -160.95% | 39.09% | 169.16% | 88.91% | -395.75% | 100.63% | 844.72% | 203.91% |
D&A (Non-Cash Add-back) | 105.5M | 106.43M | 102.95M | 26.43M | 29.11M | 33.4M | 28.23M | 25.83M | 30M | 26.58M |
EBIT | -30.37M | 106.86M | -5.11M | -42.71M | 9.67M | 56.77M | 24.94M | -20.68M | -17.22M | -22.75M |
Net Interest Income | -73.55M | -67.56M | -58.39M | -15.93M | -10.22M | -7.96M | -3.38M | 182K | -410K | -671K |
Interest Income | 0 | 1.2M | 0 | 0 | 0 | 0 | 0 | 3.22M | 2.67M | 2.41M |
Interest Expense | 73.55M | 68.76M | 58.39M | 15.93M | 10.22M | 7.96M | 3.38M | 3.04M | 3.08M | 3.08M |
Other Income/Expense | -61.74M | -5.68M | -17.49M | 71.38M | -9.98M | -8.24M | -10.52M | 2.95M | -12.72M | -12.7M |
Pretax Income | -103.92M▲ 0% | 37.98M▲ 136.5% | -211.92M▼ 658.0% | -10.78M▲ 94.9% | -553K▲ 94.9% | 31.17M▲ 5735.8% | -254.05M▼ 915.2% | -21.53M▲ 91.5% | -29.94M▼ 39.1% | -35.46M▲ 0% |
Pretax Margin % | -27.3% | 12.18% | -92.33% | -9.97% | -0.5% | 19.95% | -167.06% | -17.23% | -25.22% | -34.71% |
Income Tax | -1.43M | 1.07M | 5.28M | 17.37M | 728K | -78.46M | 77.89M | 52K | 435K | 235K |
Effective Tax Rate % | 1.38% | 2.81% | -2.49% | -161.2% | -131.65% | -251.75% | -30.66% | -0.24% | -1.45% | -0.66% |
Net Income | -102.5M▲ 0% | 36.91M▲ 136.0% | -217.2M▼ 688.5% | -28.14M▲ 87.0% | -1.28M▲ 95.4% | 109.63M▲ 8657.8% | -331.94M▼ 402.8% | -21.58M▲ 93.5% | -30.38M▼ 40.7% | -35.69M▲ 0% |
Net Margin % | -26.92% | 11.84% | -94.63% | -26.04% | -1.15% | 70.17% | -218.28% | -17.27% | -25.59% | -34.94% |
Net Income Growth % | -15.53% | 136.01% | -688.49% | 87.04% | 95.45% | 8657.77% | -402.8% | 93.5% | -40.75% | -16.59% |
Net Income (Continuing) | -102.5M | 36.91M | -217.2M | -28.14M | -1.28M | 109.63M | -331.94M | -21.58M | -30.38M | -35.69M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -98.10▲ 0% | 34.50▲ 135.2% | -184.35▼ 634.3% | -16.05▲ 91.3% | -0.45▲ 97.2% | 30.45▲ 6935.0% | -70.05▼ 330.0% | -3.45▲ 95.1% | -4.74▼ 37.4% | -5.55▲ 0% |
EPS Growth % | -12.95% | 135.17% | -634.35% | 91.29% | 97.22% | 6935.02% | -330.05% | 95.07% | -37.39% | -19.06% |
EPS (Basic) | -98.10 | 34.65 | -184.35 | -16.05 | -0.45 | 34.95 | -70.05 | -3.45 | -4.74 | - |
Diluted Shares Outstanding | 1.05M | 1.07M | 1.18M | 1.75M | 2.88M | 3.64M | 4.74M | 6.35M | 6.4M | 6.43M |
Basic Shares Outstanding | 1.05M | 1.06M | 1.18M | 1.75M | 2.88M | 3.13M | 4.74M | 6.35M | 6.4M | 6.43M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
ASRT Balance Sheet
Assertio Holdings, Inc. (ASRT) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 231.72M | 215.92M | 103.95M | 94.25M | 103.5M | 132.26M | 171.06M | 202.55M | 216.65M | 166.85M |
Cash & Short-Term Investments | 128.09M | 110.95M | 42.11M | 20.79M | 36.81M | 64.94M | 73.44M | 100.05M | 63.41M | 71.57M |
Cash Only | 128.09M | 110.95M | 42.11M | 20.79M | 36.81M | 64.94M | 73.44M | 50.59M | 10.23M | 33.71M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.47M | 53.18M | 37.86M |
Accounts Receivable | 72.48M | 37.21M | 42.74M | 44.35M | 43.75M | 45.36M | 47.66M | 54.12M | 120.11M | 61.53M |
Days Sales Outstanding | 69.49 | 43.56 | 67.97 | 149.78 | 143.85 | 105.96 | 114.4 | 158.08 | 369.3 | 354.83 |
Inventory | 13.04M | 3.4M | 3.41M | 11.71M | 7.49M | 13.7M | 37.69M | 38.31M | 24.12M | 23.01M |
Days Inventory Outstanding | 65.57 | 67.09 | 131.02 | 271.04 | 172.66 | 266.64 | 509.08 | 356.45 | 134.64 | 168.07 |
Other Current Assets | 0 | 0 | 0 | 0 | 608K | 0 | 299K | 10.07M | 9.01M | 336K |
Total Non-Current Assets | 806.9M | 716.95M | 423.22M | 209.02M | 223.05M | 281.65M | 115.36M | 82.18M | 50.32M | 44.44M |
Property, Plant & Equipment | 13.02M | 13.06M | 3.5M | 4.39M | 2.26M | 881K | 2.04M | 1.71M | 444K | 1.34M |
Fixed Asset Turnover | 29.23x | 23.86x | 65.64x | 24.61x | 49.08x | 177.34x | 74.58x | 73.03x | 267.37x | 106.77x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 793.87M | 692.1M | 400.54M | 200.08M | 216.05M | 198M | 111.33M | 80.47M | 48.91M | 43.1M |
Long-Term Investments | 0 | 11.78M | 13.06M | 1.58M | 1.58M | 268K | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 7.81M | 6.12M | 2.97M | 3.15M | 2.3M | 1.99M | 1K | 972K | 0 |
Total Assets | 1.04B▲ 0% | 932.87M▼ 10.2% | 527.17M▼ 43.5% | 303.27M▼ 42.5% | 326.55M▲ 7.7% | 413.91M▲ 26.8% | 286.42M▼ 30.8% | 284.73M▼ 0.6% | 266.97M▼ 6.2% | 211.3M▲ 0% |
Asset Turnover | 0.37x | 0.33x | 0.44x | 0.36x | 0.34x | 0.38x | 0.53x | 0.44x | 0.44x | 0.38x |
Asset Growth % | -15.24% | -10.18% | -43.49% | -42.47% | 7.67% | 26.75% | -30.8% | -0.59% | -6.24% | -18.63% |
Total Current Liabilities | 224.4M | 124.9M | 184.55M | 132.69M | 135.02M | 95.32M | 93.44M | 114.69M | 127.51M | 91.57M |
Accounts Payable | 14.73M | 6.14M | 16.19M | 14.81M | 6.68M | 5.99M | 13.44M | 14.74M | 9.01M | 5.91M |
Days Payables Outstanding | 74.07 | 121.26 | 621.82 | 342.69 | 154.12 | 116.64 | 181.54 | 137.12 | 50.32 | 64.88 |
Short-Term Debt | 82.5M | 120M | 80M | 11.94M | 12.17M | 470K | 0 | 0 | 0 | 220K |
Deferred Revenue (Current) | 135.83M | -2.37M | 86.27M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 13.29M | 2.71M | -82.5M | 20.02M | 47.65M | 30.36M | 6.09M | 96.36M | 118.5M | 84.05M |
Current Ratio | 1.03x | 1.73x | 0.56x | 0.71x | 0.77x | 1.39x | 1.83x | 1.77x | 1.70x | 1.82x |
Quick Ratio | 0.97x | 1.70x | 0.54x | 0.62x | 0.71x | 1.24x | 1.43x | 1.43x | 1.51x | 1.57x |
Cash Conversion Cycle | 60.99 | -10.61 | -422.83 | 78.13 | 162.39 | 255.97 | 441.94 | 377.41 | 453.62 | 458.02 |
Total Non-Current Liabilities | 644.71M | 587.63M | 284.66M | 115.07M | 89.11M | 92.87M | 54.97M | 48.96M | 45.51M | 44.09M |
Long-Term Debt | 544.23M | 446.11M | 271.26M | 72.16M | 61.32M | 66.4M | 38.21M | 38.81M | 39.12M | 39.25M |
Capital Lease Obligations | 0 | 0 | 4.82M | 2.81M | 397K | 0 | 1.47M | 1.12M | 0 | 1.84M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 4.27M | 4.55M | 0 | 0 | 2.43M |
Other Non-Current Liabilities | 14.3M | 20.39M | 8.58M | 40.1M | 27.4M | 22.2M | 10.74M | 9.03M | 6.38M | 4M |
Total Liabilities | 869.11M | 712.53M | 469.21M | 247.76M | 224.13M | 188.19M | 148.42M | 163.65M | 173.02M | 135.67M |
Total Debt | 626.73M | 566.11M | 358.17M | 89.6M | 75.87M | 66.87M | 39.68M | 40.27M | 39.12M | 40.31M |
Net Debt | 498.64M | 455.16M | 316.06M | 68.81M | 39.06M | 1.93M | -33.77M | -10.32M | 28.89M | 6.6M |
Debt / Equity | 3.70x | 2.57x | 6.18x | 1.61x | 0.74x | 0.30x | 0.29x | 0.33x | 0.42x | 0.53x |
Debt / EBITDA | 9.90x | 3.77x | - | - | 1.97x | 0.92x | - | 29.76x | 3.06x | 10.54x |
Net Debt / EBITDA | 7.87x | 3.03x | - | - | 1.01x | 0.03x | - | -7.63x | 2.26x | 1.73x |
Interest Coverage | -0.41x | 1.55x | -0.09x | -2.68x | 0.95x | 7.13x | 7.38x | -6.81x | -5.60x | -7.38x |
Total Equity | 169.51M▲ 0% | 220.34M▲ 30.0% | 57.96M▼ 73.7% | 55.51M▼ 4.2% | 102.41M▲ 84.5% | 225.72M▲ 120.4% | 138M▼ 38.9% | 121.08M▼ 12.3% | 93.95M▼ 22.4% | 75.63M▲ 0% |
Equity Growth % | -32.41% | 29.98% | -73.7% | -4.22% | 84.48% | 120.4% | -38.86% | -12.26% | -22.41% | -101.06% |
Book Value per Share | 162.20 | 205.89 | 49.18 | 31.77 | 35.59 | 61.93 | 29.14 | 19.06 | 14.67 | 11.76 |
Total Shareholders' Equity | 169.51M | 220.34M | 57.96M | 55.51M | 102.41M | 225.72M | 138M | 121.08M | 93.95M | 75.63M |
Common Stock | 313.86M | 6K | 8K | 3K | 4K | 5K | 9K | 9K | 1K | 1K |
Retained Earnings | -219.51M | -182.6M | -399.8M | -427.94M | -429.23M | -319.6M | -651.54M | -673.12M | -703.5M | -722.36M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -5K | -5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ASRT Cash Flow Statement
Assertio Holdings, Inc. (ASRT) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 62.17M | 72.5M | 90.47M | -65.57M | 5.52M | 78.6M | 49.6M | 26.41M | -28.18M | -7.08M |
Operating CF Margin % | 16.33% | 23.25% | 39.42% | -60.67% | 4.98% | 50.31% | 32.62% | 21.13% | -23.74% | - |
Operating CF Growth % | -5.09% | 16.62% | 24.8% | -172.48% | 108.42% | 1323.1% | -36.89% | -46.76% | -206.72% | -13552.77% |
Net Income | -102.5M | 36.91M | -217.2M | -28.14M | -1.28M | 109.63M | -331.94M | -21.58M | -30.38M | -35.69M |
Depreciation & Amortization | 105.5M | 106.43M | 102.95M | 26.43M | 29.08M | 33.4M | 28.23M | 25.83M | 30M | 26.7M |
Stock-Based Compensation | 13.02M | 12.59M | 10.6M | 10.92M | 3.54M | 7.5M | 9.16M | 5.01M | 3.45M | 2.01M |
Deferred Taxes | -8.72M | 1.27M | -5.77M | -8.42M | 0 | -80.38M | 76.2M | 0 | 0 | 0 |
Other Non-Cash Items | 36.53M | 22.51M | 200.51M | -22.15M | 5.48M | 21.46M | 267.82M | 11.95M | 14.07M | 4.46M |
Working Capital Changes | 18.34M | -107.2M | -606K | -44.21M | -31.29M | -13.01M | 140K | 5.2M | -45.33M | -4.56M |
Change in Receivables | 30.14M | 35.27M | -5.53M | 19.8M | -11K | -996K | 48.67M | -6.46M | -65.99M | 4.76M |
Change in Inventory | -1.87M | 9.05M | -316K | -291K | 4.27M | -6.59M | -4.97M | -9.58M | 9.68M | 12.22M |
Change in Payables | -6.44M | -33.61M | -15.15M | -36.48M | -28.7M | -10.11M | -29.35M | -1.26M | -13.29M | -11.7M |
Cash from Investing | 57.89M | -7.08M | -1.48M | 512.8M | -18.52M | -42.67M | 3.1M | -48.91M | -11.99M | 6.06M |
Capital Expenditures | -666K | -5.51M | -1.48M | -10K | -53K | -274K | -628K | 0 | 0 | 0 |
CapEx % of Revenue | 0.17% | 1.77% | 0.65% | 0.01% | 0.05% | 0.18% | 0.41% | - | - | 0% |
Acquisitions | 280K | 145K | 0 | 506.81M | -18.47M | -42.4M | 1.53M | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 280K | 80K | 0 | 0 | 0 | 0 | 0 | 0 | -8.17M | -11.99M |
Cash from Financing | -110.89M | -81.35M | -157.84M | -468.55M | 29.03M | -7.79M | -44.2M | -350K | -189K | -267K |
Debt Issued (Net) | -110M | -82.5M | -153.25M | -454.26M | -9.84M | -750K | -10.5M | 0 | 0 | 0 |
Equity Issued (Net) | 8.19M | 1.33M | -570K | -778K | 44.44M | 6.18M | -7.9M | -350K | 0 | -7K |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -753K | -686K | -570K | -866K | -418K | -838K | -7.9M | -350K | 0 | -7K |
Other Financing | -9.07M | -184K | -4.02M | -13.52M | -5.58M | -13.23M | -25.8M | 0 | -189K | -260K |
Net Change in Cash | 9.18M▲ 0% | -15.94M▼ 273.7% | -68.84M▼ 332.0% | -21.32M▲ 69.0% | 16.02M▲ 175.2% | 28.13M▲ 75.6% | 8.5M▼ 69.8% | -22.85M▼ 368.9% | -40.36M▼ 76.6% | -1.29M▲ 0% |
Free Cash Flow | 61.5M▲ 0% | 66.99M▲ 8.9% | 88.99M▲ 32.8% | -65.58M▼ 173.7% | 5.47M▲ 108.3% | 78.32M▲ 1331.9% | 48.98M▼ 37.5% | 26.41M▼ 46.1% | -28.18M▼ 206.7% | -7.08M▲ 0% |
FCF Margin % | 16.15% | 21.49% | 38.77% | -60.68% | 4.93% | 50.13% | 32.21% | 21.13% | -23.74% | -6.93% |
FCF Growth % | -1.82% | 8.93% | 32.85% | -173.69% | 108.34% | 1331.88% | -37.47% | -46.08% | -206.72% | -211.3% |
FCF per Share | 58.85 | 62.60 | 75.51 | -37.53 | 1.90 | 21.49 | 10.34 | 4.16 | -4.40 | -1.10 |
FCF Conversion (FCF/Net Income) | -0.61x | 1.96x | -0.42x | 2.33x | -4.31x | 0.72x | -0.15x | -1.22x | 0.93x | 0.20x |
Interest Paid | 55.54M | 48.44M | 37.79M | 17.6M | 10.12M | 7.75M | 3.65M | 2.6M | 0 | 1.3M |
Taxes Paid | 121K | 6.47M | 4.4M | 0 | 0 | 0 | 4.03M | 1.59M | 0 | 0 |
ASRT Key Ratios
Assertio Holdings, Inc. (ASRT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -48.77% | 18.93% | -156.1% | -49.61% | -1.62% | 66.82% | -182.52% | -16.66% | -28.25% | -38.72% |
Return on Invested Capital (ROIC) | -4.33% | 4.87% | -27.79% | -24.73% | 5.32% | 16.01% | -110.07% | -17.08% | -11.06% | -17.17% |
Gross Margin | 80.93% | 94.07% | 95.86% | 85.41% | 85.74% | 88% | 82.23% | 68.61% | 44.92% | 44.32% |
Net Margin | -26.92% | 11.84% | -94.63% | -26.04% | -1.15% | 70.17% | -218.28% | -17.27% | -25.59% | -34.94% |
Debt / Equity | 3.70x | 2.57x | 6.18x | 1.61x | 0.74x | 0.30x | 0.29x | 0.33x | 0.42x | 0.53x |
Interest Coverage | -0.41x | 1.55x | -0.09x | -2.68x | 0.95x | 7.13x | 7.38x | -6.81x | -5.60x | -7.38x |
FCF Conversion | -0.61x | 1.96x | -0.42x | 2.33x | -4.31x | 0.72x | -0.15x | -1.22x | 0.93x | 0.20x |
Revenue Growth | -16.49% | -18.11% | -26.38% | -52.91% | 2.72% | 40.73% | -2.67% | -17.83% | -5% | -14.16% |
Related:ASRT Dividend History·ASRT Revenue History·ASRT Price History·ASRT P/E History·ASRT Financial Ratios·ASRT Institutional Holders
ASRT SEC Filings & Documents
Assertio Holdings, Inc. (ASRT) SEC filings — annual & quarterly reports (10-K, 10-Q)
ASRT Frequently Asked Questions
Assertio Holdings, Inc. (ASRT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Assertio Holdings, Inc. (ASRT) reported $102.2M in revenue for fiscal year 2025. This represents a 33952% increase from $0.3M in 1996.
Assertio Holdings, Inc. (ASRT) saw revenue decline by 5.0% over the past year.
Assertio Holdings, Inc. (ASRT) reported a net loss of $35.7M for fiscal year 2025.
Dividend & Returns
Assertio Holdings, Inc. (ASRT) has a return on equity (ROE) of -28.3%. Negative ROE indicates the company is unprofitable.
Assertio Holdings, Inc. (ASRT) had negative free cash flow of $7.1M in fiscal year 2025, likely due to heavy capital investments.